Literature DB >> 2902106

Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay.

B Niklasson1, T Kjelsson.   

Abstract

Nephropathia epidemica (NE), a less severe form of hemorrhagic fever with renal syndrome, is caused by Puumala virus (PUU). This communication reports the development of a mu-capture enzyme-linked immunosorbent assay (ELISA) for detection of specific immunoglobulin M (IgM) antibodies to PUU virus in human sera. Acute- and early-convalescent-phase sera (collected 1 to 41 days after disease onset) from 29 Swedish patients with clinical NE were tested for PUU virus-specific IgG and IgM antibodies by the indirect immunofluorescence test and ELISA, respectively. Late-convalescent-phase serum was also collected from 18 of these patients 3 to 24 months postinfection and assayed. The IgM ELISA values were strongly positive in sera collected during the first 2 months; at 3 to 9 months, they were negative or in the lower range of significance, and at 24 months all sera were negative. Paired sera from NE patients often fail to show seroconversion or a significant titer rise when tested by indirect immunofluorescence. Since all acute- and early-convalescent-phase sera were positive by IgM ELISA, this test could become an important tool for early diagnosis of acute human NE infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902106      PMCID: PMC266653          DOI: 10.1128/jcm.26.8.1519-1523.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Elimination of inter-species reactive anti-IgG antibodies by affinity chromatography.

Authors:  M E Johansson; J A Espmark
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

2.  Isolation of the nephropathia epidemica agent in Sweden.

Authors:  B Niklasson; J Le Duc
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

3.  Preparation of specific antisera against adenoviruses by affinity bead immunization (ABI).

Authors:  M E Johansson; G Wadell; P A Jacobsson; L Svensson
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

4.  Persistence of specific IgM after natural infection with rubella virus.

Authors:  J R Pattison
Journal:  Lancet       Date:  1975-01-25       Impact factor: 79.321

5.  Specific immunoglobulin M response to hepatitis A virus determined by solid-phase radioimmunoassay.

Authors:  S M Lemon; C D Brown; D S Brooks; T E Simms; W H Bancroft
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

6.  Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica.

Authors:  K Penttinen; J Lähdevirta; R Kekomäki; B Ziola; A Salmi; A Hautanen; P Lindström; A Vaheri; M Brummer-Korvenkontio; O Wager
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

7.  Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay.

Authors:  E M Salonen; A Vaheri; J Suni; O Wager
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

8.  Antibodies to the HFRS virus in the human population of European RSFSR as detected by radioimmunoassay.

Authors:  G V Rezapkin; Z V Shuikova; E A Tkachenko; A A Ivanova; R G Nurgaleeva; A G Stepanenko; N N Vereshchagin; A I Loginov; R N Bagan
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

9.  An epidemiological survey of nephropathia epidemica in Sweden.

Authors:  B Niklasson; L Nyman; A Linde; M Grandien; J Dalrymple
Journal:  Scand J Infect Dis       Date:  1983

10.  Nephropathia epidemica: incidence of clinical cases and antibody prevalence in an endemic area of Sweden.

Authors:  B Niklasson; J Leduc; K Nyström; L Nyman
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

View more
  11 in total

1.  A novel mu-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome.

Authors:  L G Zöller; S Yang; P Gött; E K Bautz; G Darai
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

2.  Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells.

Authors:  O Vapalahti; A Lundkvist; H Kallio-Kokko; K Paukku; I Julkunen; H Lankinen; A Vaheri
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  [Acute hantavirus infection caused by a genetically newly identified viral strain. Severe and complicated course of hemorrhagic fever with renal syndrome (nephropathia epidemica)].

Authors:  B Lauer; M Wiemer; A Kramer; J Pilaski; P Heering; D Horstkotte; H P Schultheiss; B E Strauer
Journal:  Med Klin (Munich)       Date:  1999-01-15

4.  Evaluation of serological methods for diagnosis of Puumala hantavirus infection (nephropathia epidemica).

Authors:  K B Sjölander; F Elgh; H Kallio-Kokko; O Vapalahti; M Hägglund; V Palmcrantz; P Juto; A Vaheri; B Niklasson; A Lundkvist
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

5.  Puumala virus antibody and immunoglobulin G avidity assays based on a recombinant nucleocapsid antigen.

Authors:  H Kallio-Kokko; O Vapalahti; K Hedman; M Brummer-Korvenkontio; A Vaheri
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

6.  The humoral response to Puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays.

Authors:  A Lundkvist; J Hörling; B Niklasson
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Detection and subsequent sequencing of Puumala virus from human specimens by PCR.

Authors:  J Hörling; A Lundkvist; K Persson; M Mullaart; T Dzagurova; A Dekonenko; E Tkachenko; B Niklasson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

8.  Hemorrhagic fever with renal syndrome: a study of sequelae following nephropathia epidemica.

Authors:  B Niklasson; G Hellsten; J LeDuc
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Anti-idiotypic antibodies against Puumala virus glycoprotein-specific monoclonal antibodies inhibit virus infection in cell cultures.

Authors:  A Lundkvist; C Scholander; B Niklasson
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Mapping of B-cell determinants in the nucleocapsid protein of Puumala virus: definition of epitopes specific for acute immunoglobulin G recognition in humans.

Authors:  A Lundkvist; S Björsten; B Niklasson; N Ahlborg
Journal:  Clin Diagn Lab Immunol       Date:  1995-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.